Hsiao, Michael

  • Wen-Der Lin, Chia-Hao Chang, Jhih-Kai Pan, Forn-Chia Lin, Yu-Chia Chen, Ya-Jyun Chen, Po-Shun Wang, Cheng-Han Lin, Yao-Lung Kuo, Wei-Pang Chung, Hui-Chuan Cheng, Michael Hsiao, Chia-Ning Yang, Wei-Qiao Hong, Sheng-Yuan Chen, Pei-Jung Lu, 2024, “A novel long non-coding RNA MIR4500HG003 promotes tumor metastasis through miR-483-3p-MMP9 axis in triple negative breast cancer”, CELL DEATH & DISEASE, 1, 1. (SCIE)
  • Lin Ying-Chu, Wuputra Kenly, Kato Kohsuke, Ku Chia-Chen, Saito Shigeo, Noguchi Michiya, Nakamura Yukio, Hsiao Michael, Lin Chang-Shen, Wu Deng-Chyang, Kawaguchi Atsushi, Yu Hsin-Su, Yokoyama Kazunari K., 2024, “Di-n-butyl Phthalate Promotes the Neural Differentiation of Mouse Embryonic Stem Cells through Neurogenic Differentiation 1”, ENVIRONMENTAL POLLUTION, 3, 123722. (SCIE)
  • Senthilkumar Thirumurugan, Susaritha Ramanathan, Kayalvizhi Samuvel Muthiah, Yu-Chien Lin, Michael Hsiao, Udesh Dhawan, An-Ni Wang, Wai-Ching Liu, Xinke Liu, Mei-Yi Liao, Ren-Jei Chung, 2024, “Inorganic Nanoparticles for Photothermal Treatments of Cancer”, JOURNAL OF MATERIALS CHEMISTRY B, 1, 1. (SCIE)
  • Wu Chin-Jui, Pan Ke-Fan, Chen Ji-Qing, Tao Yu -Chen, Liu Yu-Cheng, Chen Bo-Rong, Hsu Ching, Wang Ming-Yang, Sheu Bor-Ching, Hsiao Michael, Hua Kuo-Tai, Wei Lin-Hung, 2024, “Loss of LECT2 Promotes Ovarian Cancer Progression by Inducing Cancer Invasiveness and Facilitating An Immunosuppressive Environment”, ONCOGENE, 43(7), 511-523. (SCIE)
  • Chang Yu‐Chan, Yang Yi‐Fang, Li Chien‐Hsiu, Chan Ming‐Hsien, Lu Meng‐Lun, Chen Ming‐Huang, Chen Chi‐Long, Hsiao Michael*, 2024, “RAB31 Drives Extracellular Vesicle Fusion and Cancer‐associated Fibroblast Formation Leading to Oxaliplatin Resistance in Colorectal Cancer”, JOURNAL OF EXTRACELLULAR BIOLOGY, 3(2), 1. (SCIE)
  • Ngo Loan Thi, Huang Wen‐Tse, Chan Ming‐Hsien, Su Ting‐Yi, Li Chien‐Hsiu, Hsiao Michael*, Liu Ru‐Shi, 2024, “Comprehensive Neurotoxicity of Lead Halide Perovskite Nanocrystals in Nematode Caenorhabditis elegans”, SMALL, 20(2), e2306020. (SCIE)
  • Chien Ming-Hsien, Yang Yi-Chieh, Ho Kuo-Hao, Ding Yi-Fang, Chen Li-Hsin, Chiu Wen-Kuan, Chen Ji-Qing, Tung Min-Che, Hsiao Michael, Lee Wei-Jiunn, 2024, “Cyclic Increase in the ADAMTS1-L1CAM-EGFR Axis Promotes the EMT and Cervical Lymph Node Metastasis of Oral Squamous Cell Carcinoma”, CELL DEATH & DISEASE, 15(1), 82. (SCIE)
  • Ho Chiu-Yi, Sun Gwo-Ching, Lin Yu-Te, Wong Tzyy-Yue, Hsiao Michael, Tseng Ching-Jiunn, Cheng Pei-Wen, 2024, “Microglial Activation and Toll-like Receptor 4-Dependent Regulation of Angiotensin II Type I Receptor-mu-opioid Receptor 1 Heterodimerization and Hypertension in Fructose-fed Rats”, EUROPEAN JOURNAL OF PHARMACOLOGY, 962, 176171. (SCIE)

Lin, Kuo-I

  • Chou, S.-C., Yen, C.-T., Yang, Y.-L., Chen, S.-H., Wang, J.-D., Fan, M.-N., Chen, L.-F., Yu, I-S., Tsai, D.-Y., Lin, K.-I, Tao, M.-H., Wu, J.-C., and Lin, S.-W., 2024, “Recapitulating the immune system of hemophilia A patients with inhibitors using immunodeficient mice”, Thrombosis Research, 235, 155-163. (SCIE)
  • Huang, C.-H., Yang, T.-T. and Lin, K.-I*., 2024, “Mechanisms and functions of SUMOylation in health and disease: a review focusing on immune cells”, J Biomed Sci., 31(1), 16. (SCIE)

Shen, Chia-Ning

  • Huang, Y.K., W.C. Cheng, J.C. Yang, Y.C. Wu, H.H. Wu, T.T. Kuo, C.C. Lo, C.Y. Hsieh, S.C. Wong, C.H. Lu, C.N. Shen, M.C. Hung, J.T. Lin, C.C. Yeh, Y.P. Sher., 2024, “Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy”, Nature Cancer, DOI:, 10.1038/s43018-023-00720-x. (SCIE)

Yang, Hwai-I

  • Lee MH, Chen YT, Huang YH, Lu SN, Yang TH, Huang JF, Yin SC, Yeh ML, Huang CF, Dai CY, Chuang WL, Yu ML, Yang HI, Chen HY, Chen CJ, 2024, “Chronic Viral Hepatitis B and C Outweigh MASLD in the Associated Risk of Cirrhosis and HCC.”, CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, S1542-3565(24)00198-8, doi: 10.1016/j.cgh.2024.01.045. (SCIE)
  • Lin HC, Jeng WJ, Liu J, Pan MH, Lee MH, Batrla-Utermann R, Lu SN, Chen CF, Yang HI*, Chen CJ, 2024, “Persistently high HBsAg levels during HBeAg-seropositive stage predict lower risk of hepatocellular carcinoma in chronic hepatitis B patients.”, ALIMENTARY PHARMACOLOGY & THERAPEUTICS, doi: 10.1111/apt.17915, Online ahead of print. (SCIE)